Search peptides, terms, sources/
Research source · 2025

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5)

About this source

Kind
Research
Design
Human clinical trial, RCT
Population
Adults with obesity, without type 2 diabetes
Sample size
751 randomised 1:1
Primary or secondary
primary
Peer review
peer reviewed
Retraction status
None known
Date checked
14 November 2026

Limitations

Sponsor-funded (Eli Lilly). Open-label design. Head-to-head comparison with another company's medicine.

Cited in

Spotted an error? Report a problem with this page. We correct the record and log every change on What's changed.